Y mAbs Therapeutics
Price & Volume
Stats
See moreOpen | $6.15 |
Previous Close | $6.16 |
Day Range | $6.12-$6.27 |
52W Range | $6.01-$20.90 |
Market Cap | $275.9M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $84.5M |
Revenue Growth (YoY) | -9.7% |
Gross Profit (12 Mos) | $75.1M |
Diluted EPS | -$0.54 |
News
See moreYahoo Finance • 5 months ago
Y-mAbs Therapeutics, Inc. (YMAB): One of Caligan Partners’ Top Holdings Now?
Yahoo Finance • 12 months ago
Here's Why We're Not At All Concerned With Y-mAbs Therapeutics' (NASDAQ:YMAB) Cash Burn Situation
Yahoo Finance • last year
Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
About
CEO | Mr. Michael Rossi |
CFO | Mr. Peter P. Pfreundschuh CPA |
Address | 230 Park Avenue, New York, NY, United States, 10169 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |
